Steady Expansion Forecast for Stents Market, Projected to Reach $14.77 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Stents Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the size of the stents market has experienced consistent growth. The forecast suggests it will expand from $11.26 billion in 2024 to $11.81 billion in 2025, with a compound annual growth rate (CAGR) of 4.8%. This growth in the historical period can be attributed to several factors. These include the rising occurrence of cardiovascular diseases, an aging demographic, heightened awareness of minimally invasive procedures, escalation in healthcare expenditures, increased adoption of drug-eluting stents, and a growing count of angioplasty procedures.

Stents Market Size Forecast: What's the Projected Valuation by 2029?
The stents market is anticipated to undergo substantial expansion in the upcoming years, escalating to a value of $14.77 billion in 2029, with a compound annual growth rate (CAGR) of 5.8%. Factors propelling this growth over the forecast period include enhanced government healthcare initiatives, a rising prevalence of diabetes, an increase in high-risk patient numbers, growing demand for personalized stents, and improved collaboration between hospitals and medical device producers. Noteworthy trends in this forecasted period encompass advancements in stent technology, the growth of healthcare infrastructure in budding markets, 3D-printed stents, the reduction in stent size for minor arteries, and the use of robots for stent deployment.

View the full report here:
https://www.thebusinessresearchcompany.com/report/stents-global-market-report

What Are the Drivers Transforming the Stents Market?
The escalating numbers of cardiovascular disorders are set to fuel the expansion of the stents market. Cardiovascular disorders are health issues that impair the heart or blood vessels, thus inhibiting the proper functioning of the heart. This increase can be attributed to a sedentary lifestyle, which can lead to obesity, hypertension and decreased cardiovascular health by impacting the efficiency of the heart and blood circulation. The placement of stents assists in managing cardiovascular disorders by re-establishing and preserving blood flow in constricted or occluded arteries which helps in diminishing the threat of heart attacks and other complications. For example, the British Heart Foundation, a cardiovascular research charity based in the UK, reported that around 7.6 million individuals in the UK, comprising approximately 4 million men and 3.6 million women, were suffering from heart and circulatory diseases as of January 2025. These diseases account for nearly 27% of all deaths in the nation, resulting in over 170,000 deaths annually, or essentially 480 fatalities per day. Hence, the ascendance in cardiovascular disorders is accelerating the growth of the stent market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24408&type=smp

What Trends Will Shape the Stents Market Through 2029 and Beyond?
Innovative technologies such as drug-eluting stents are being developed by leading companies in the stent market to boost efficiency, lower restenosis rates, and improve patient results. Drug-eluting stents, tiny mesh tubes utilized in arteries, gradually release medication to inhibit the artery from constricting after treatment. For instance, in August 2022, an Ireland-based medical technology enterprise, Medtronic plc, introduced its newest drug-eluting coronary stent system, the Onyx Frontier, after receiving CE Mark authorization. This state-of-the-art stent is an advancement of the Resolute Onyx model, featuring upgrades such as a novel dual-layer balloon, a reduced crossing profile, and heightened catheter flexibility. These enhancements result in a 16% improvement in deliverability relative to the prior generation, without sacrificing radial strength. The Onyx Frontier comes in a wide range of sizes, from 2.0mm to 5.0mm, with 4.50-5.00mm dimensions expandable up to 6.00mm, purposefully created to support extra-large vessels, including the left main.

Which Segments in the Stents Market Offer the Most Profit Potential?
The stents market covered in this report is segmented -

1) By Product: Coronary Stents, Peripheral Stents, Stent-Related Implants, Biliary Stents, Carotid Stents, Neurovascular Stents
2) By Material: Metallic Biomaterial, Polymer Biomaterial, Natural Biomaterial
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End User

Subsegments:
1) By Coronary Stents: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
2) By Peripheral Stents: Iliac Artery Stents, Femoral-Popliteal Artery Stents, Renal Artery Stents, Tibial Artery Stents
3) By Stent-Related Implants: Stent Grafts, Endovascular Stent Grafts, Covered Stents
4) By Biliary Stents: Plastic Biliary Stents, Metallic Biliary Stents, Self-Expanding Biliary Stents
5) By Carotid Stents: Balloon-Expandable Carotid Stents, Self-Expanding Carotid Stents
6) By Neurovascular Stents: Flow Diverter Stents, Self-Expanding Neurovascular Stents, Balloon-Expandable Neurovascular Stents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24408&type=smp

Which Firms Dominate the Stents Market by Market Share and Revenue in 2025?
Major companies operating in the stents market are Abbott Laboratories, Medtronic plc, Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Terumo Corporation, Teleflex Incorporated, Cook Group Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Micro-Tech Europe, Meril Life Sciences, MicroPort Scientific Corporation, Biosensors International Group Ltd., Novatech SA, Elixir Medical Corporation, Vascular Concepts Ltd., Veryan Medical Limited

Which Regions Offer the Highest Growth Potential in the Stents Market?
North America was the largest region in the stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24408

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.